Axsome Therapeutics, Inc. (AXSM): Shareholders' Equity
$88.30M
As of 2025-12-31
$83.30M
As of 2026-06-30
-6.9%
3-year compound annual growth
-4.9%
5-year compound annual growth
+6.6%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $88.30M | +54.9% | 2026-02-23, Balance as of period end |
| 2024-12-31 | $57.02M | -70.1% | 2026-02-23, Balance as of period end |
| 2023-12-31 | $190.98M | +74.3% | 2026-02-23, Balance as of period end |
| 2022-12-31 | $109.56M | +600.9% | 2025-02-18, Balance as of period end |
| 2021-12-31 | $15.63M | -86.3% | 2024-02-23, Balance as of period end |
| 2020-12-31 | $113.79M | -36.3% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $178.72M | n/m | 2022-03-01, Balance as of period end |
| 2018-12-31 | $937.9K | -94.4% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $16.72M | -22.5% | 2020-03-12, Balance as of period end |
| 2016-12-31 | $21.57M | -53.6% | 2019-03-15, Balance as of period end |
| 2015-12-31 | $46.44M | n/m | 2018-03-07, Balance as of period end |
| 2014-12-31 | -$3.20M | n/a | 2017-03-07, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $88.30M | +54.9% |
| TG Therapeutics, Inc. (TGTX) | 2025-12-31 | $648.02M | +191.4% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $1.27B | -7.1% |
| Insmed Inc (INSM) | 2025-12-31 | $738.98M | +158.9% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | -$80.00M | n/m |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $567.61M | +29.5% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $1.06B | +2.5% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $788.80M | +7.7% |
| Organogenesis Holdings Inc. (ORGO) | 2025-12-31 | $300.13M | +14.2% |
Compare AXSM, TGTX, OPK, INSM side by side · Screen every company in Pharmaceutical Preparations ↗